Neurocrine Biosciences, Inc.

479 articles with Neurocrine Biosciences, Inc.

• Pharmacopeia Drug Discovery And Neurocrine Biosciences, Inc. Expand Drug Discovery And Development Collaboration

  3/15/2006

• Neurocrine Biosciences, Inc. Kills MS Program After Phase II Clinical Failure

  3/8/2006

• Neurocrine Biosciences, Inc. To Present At The SG Cowen & Co., LLC 26th Annual Healthcare Conference

  3/6/2006

• Merrill Lynch To Present At The Merrill Lynch Global Conference

  2/6/2006

• Neurocrine Biosciences, Inc. Reports Fourth Quarter And Year-End 2005 Results

  1/24/2006

• Neurocrine Biosciences, Inc. Announces Conference Call For Fourth Quarter And Year-End 2005 Financial Results

  1/17/2006

• Neurocrine Biosciences, Inc. Provides Update Of FDA's Review Of Indiplon

  1/11/2006

• Neurocrine Biosciences, Inc. To Present At The 24th Annual JP Morgan Healthcare Conference

  1/10/2006

• Neurocrine Biosciences, Inc. Announces Positive Phase II Safety And Efficacy Results With Urocortin 2 For Congestive Heart Failure

  12/19/2005

• Neurocrine Biosciences, Inc. Announces The Appointment Of Adrian Adams To The Board Of Directors

  12/8/2005

• Neurocrine Biosciences, Inc. Takes Delivery Of Genedata’s Computational High Throughput Gene Expression Analysis System

  12/7/2005

• Neurocrine Biosciences, Inc. To Present At CIBC World Markets 'Best Ideas' Conference

  11/28/2005

• Neurocrine Biosciences, Inc. To Present At The CIBC 16th Annual Healthcare Conference

  11/7/2005

• Neurocrine Biosciences, Inc. Announces Appointment Of Senior Vice President Of Clinical Development

  11/1/2005

• Neurocrine Biosciences, Inc. Reports Third Quarter 2005 Results

  10/25/2005

• Neurocrine Biosciences, Inc. Announces Conference Call For Third Quarter 2005 Financial Results

  10/24/2005

• Ten Drugs To Watch

  2/24/2005

• Neurocrine Drug Helps Elderly Insomniacs Sleep

  3/2/2004

• Bedside Biotechs

  11/3/2003